| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $52.02B | +18.3% |
| R&D Expense | $3.40B | +9.4% |
| SG&A Expense | $3.24B | -10.9% |
| Operating Income | $5.57B | +98.8% |
| Pre-tax Income | $5.80B | +40.6% |
| Income Tax | -$4.35B | +24.5% |
| Net Income | $10.05B | +2.0% |
| EPS (Basic) | $4.82 | +2.3% |
| EPS (Diluted) | $4.73 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.11B | +20.6% |
| Short-term Investments | $528.0M | -51.3% |
| Accounts Receivable | $3.83B | +14.8% |
| Current Assets | $13.99B | +14.3% |
| Total Assets | $61.80B | +20.6% |
| Current Liabilities | $12.32B | +7.4% |
| Long-term Debt | $10.60B | +10.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.10B | +41.5% |
| Capital Expenditures | $336.0M | +38.8% |
| Investing Cash Flow | -$3.56B | -12.2% |
| Financing Cash Flow | -$5.71B | -173.7% |
| Free Cash Flow | $9.76B | +41.6% |
| +3.7% |
| Total Liabilities |
| $33.72B |
| +17.2% |
| Stockholders' Equity | $27.04B | +25.4% |